By Mill Chart
Last update: Aug 7, 2025
Aspen Aerogels Inc (NYSE:ASPN) reported its second-quarter 2025 financial results, delivering mixed performance against analyst expectations. The company posted revenue of $78.0 million, a 1% sequential decline but a 5.5% beat compared to the consensus estimate of $73.98 million. Gross margins improved to 32%, up three percentage points from the previous quarter, reflecting cost structure improvements.
The company’s net loss narrowed significantly to $9.1 million (or -$0.11 per share), which included $5.9 million in restructuring and impairment charges. Excluding these one-time items, the adjusted net loss was $3.2 million (-$0.04 per share), outperforming the estimated -$0.09 EPS.
The stock is up 9.7% in pre-market trading, signaling a positive reaction to the earnings beat and improved profitability metrics. Over the past month, shares have gained 20.3%, reflecting growing investor confidence ahead of the earnings release.
Management provided guidance for the second half of 2025, expecting:
The outlook suggests continued margin expansion, supported by cost reductions and operational streamlining.
Aspen Aerogels’ Q2 results reflect progress in improving margins and profitability, particularly in its Thermal Barrier segment. The market’s positive reaction underscores relief over the earnings beat and optimism around the company’s restructuring efforts.
For detailed earnings estimates and historical performance, see Aspen Aerogels’ earnings data.
Disclaimer: This article is not investment advice. Investors should conduct their own research before making decisions.
8.24
-0.02 (-0.24%)
Find more stocks in the Stock Screener